CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

A silent killer HCV (Hepatitis C virus) in India: A Review of prevalence from all available data

Author: 
Priya Madan Yabaji, Dr. Aruna Shankar kumar and Dr. Kanjaksha Ghosh
Subject Area: 
Health Sciences
Abstract: 

This article reviews the prevalence of and factors associated with HCV infection in Indian population. Total 109 different studies were included in this study. Literature search was done by using keywords ‘hepatitis C virus prevalence in India’, ‘HCV and India’, ‘hepatitis and India’ through electronic databases like Pubmed, Google Scholar. Blood donors constituted the largest data of 15,61,371 individuals. The frequency was highest in injecting drug users i.e. 51.22 % (95% CI: 50.80 – 51.64). The frequency in multitransfused thalassemics and haemophiliac cases was 22.78 % (95% CI: 22.00– 23.55) and 14.38 %( 95% CI: 13.21 – 15.55) respectively. The frequency in pregnant women was 1.07% (95% CI: 0.983 - 1.017). The frequency due to sexual transmission and haemodialyis was 5.82% (95% CI: 5.646 - 5.994) and 4.73% (95% CI: 4.33 – 5.13) respectively. The serofrequency in communities and hospital –based population was 8.03% (95% CI: 7.75 – 8.30) and 0.45% (95% CI : 0.43 – 0.47) respectively. The frequency in liver disease patients was 19.71 (95% CI: 19.24 – 20.18).This study reviewed HCV seroprevalence among different groups from India which would help to identify high prevalence areas and to introduce the most effective measures to prevent its further transmission and the necessary awareness of this silent epidemic.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran